EPTIS
BAM Logo

POCT Haemoglobin

[POCT Haemoglobin]

EPTIS factsheet 142674 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts142674 https://www.eptis.bam.de/pts142674

PT provider
PT provider Weqas Weqas
Based in United Kingdom
Language(s)
Remarks Haemoglobin (Hb) is the iron containing oxygen transport metalloprotein in red blood cells and is one of the most common laboratory tests performed. The test is used to detect and measure the severity of anaemia, monitor the response to treatment, and help make decisions about blood transfusions. Iron deficiency Anaemia is defined as a Hb < 130 g/L in men aged over 15 years, and <120 g/L in non-pregnant women aged over 15 years or children aged 12–14 years, and < 110 g/L during pregnancy. An Hb level of 110 g/L or more appears adequate in the first trimester, and a level of 105 g/L appears adequate in the second and third trimesters. Postpartum a Hb < 100 g/L is consistent with anaemia. POCT Hb is usually undertaken when a fast turnaround time is needed for immediate therapeutic decisions and are often used in the identification and management of anaemia in the perioperative pathway. POCT Hb can be measured on a blood gas analyser (BGA), and on specific POCT devices. The material is purified stroma free bovine haemolysate, requiring no prior preparation. Two samples are distributed bimonthly, with a minimum of 12 samples distributed over the year covering a wide, clinically relevant range. The samples consist of a panel of 5 samples distributed on a number of occasions over that period, which are used to assess both the user and device performance, including linearity, bias, within and between batch imprecision. Key Features: - Ready to use samples in dropper bottles, no need for reconstitution. - Panel of samples distributed covering the pathological range. - Programme assesses both user and device performance, including linearity, bias, within and between batch imprecision. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-haemoglobin/ or contact@weqas.com
Keywords
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Purified bovine haemolysate Haemoglobin Routine testing methods (recommended)
Aims of the PT scheme
Target group of participants The POCT Hb EQA Programme is specifically designed for the quantitative assay of Hb using a POCT Hb device, for Hb measurement using a BGA please refer to our Blood Gas/Co-oximetry EQA Programme.
Linked to specific legislation / standards Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/ IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee https://www.weqas.com/participantzone/subscription-charges/
Regularly operated Yes (Frequency: Bimonthly. Samples: 2 x 1.0mL. )
Year of first operation 2007
Contact details of the PT provider
Provider Contact person
Weqas
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Phone: 44 (0) 2920 314750
Fax:
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884
Fax:
Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5